Dongqin Yang

3.0k total citations · 1 hit paper
84 papers, 2.3k citations indexed

About

Dongqin Yang is a scholar working on Molecular Biology, Cancer Research and Materials Chemistry. According to data from OpenAlex, Dongqin Yang has authored 84 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 17 papers in Cancer Research and 14 papers in Materials Chemistry. Recurrent topics in Dongqin Yang's work include Advanced Nanomaterials in Catalysis (14 papers), Nanoplatforms for cancer theranostics (12 papers) and Ubiquitin and proteasome pathways (11 papers). Dongqin Yang is often cited by papers focused on Advanced Nanomaterials in Catalysis (14 papers), Nanoplatforms for cancer theranostics (12 papers) and Ubiquitin and proteasome pathways (11 papers). Dongqin Yang collaborates with scholars based in China, United States and Japan. Dongqin Yang's co-authors include Zhiling Zhu, Ning Sui, Yixin Yu, Qiang Bai, Lina Wang, Yujie Jiang, Manman Liang, Limin Shang, William W. Yu and Chaohui Zhang and has published in prestigious journals such as Advanced Materials, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Dongqin Yang

82 papers receiving 2.3k citations

Hit Papers

Ultrasound-Augmented Multienzyme-like Nanozyme Hydrogel S... 2023 2026 2024 2025 2023 50 100 150 200

Peers

Dongqin Yang
Yong Weon Yi South Korea
Haopeng Xiao United States
Dongqin Yang
Citations per year, relative to Dongqin Yang Dongqin Yang (= 1×) peers Hongbo Xin

Countries citing papers authored by Dongqin Yang

Since Specialization
Citations

This map shows the geographic impact of Dongqin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongqin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongqin Yang more than expected).

Fields of papers citing papers by Dongqin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongqin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongqin Yang. The network helps show where Dongqin Yang may publish in the future.

Co-authorship network of co-authors of Dongqin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Dongqin Yang. A scholar is included among the top collaborators of Dongqin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongqin Yang. Dongqin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Dongqin, Yan Meng, Jian Guo, & Lingyun Wu. (2025). Hypermethylation of microRNA-34c CpG Island predicts unfavorable prognosis in acute myeloid leukemia. Scientific Reports. 15(1). 35165–35165.
2.
Gao, Yonghui, Le Zhu, Lumin Zhang, et al.. (2025). Rational Design of Single‐Atom Nanozymes for Combination Cancer Immunotherapy. Advanced Functional Materials. 35(10). 10 indexed citations
3.
Cheng, Mingyang, Yu Sun, Junhong Wang, et al.. (2024). ASB3 expression aggravates inflammatory bowel disease by targeting TRAF6 protein stability and affecting the intestinal microbiota. mBio. 15(9). e0204324–e0204324. 2 indexed citations
4.
Yang, Dongqin, et al.. (2024). The Impact of Park Green Space Areas on Urban Vitality: A Case Study of 35 Large and Medium-Sized Cities in China. Land. 13(10). 1560–1560. 2 indexed citations
5.
Sheth, Sunil G., et al.. (2024). Type 2 innate immunity promotes the development of pulmonary fibrosis in Hermansky-Pudlak syndrome. JCI Insight. 9(22). 5 indexed citations
6.
Mo, Xiao‐Dong, He Huang, Feng Chen, et al.. (2024). A Phase II Study to Evaluate the Efficacy and Safety of Pimicotinib (ABSK021) in Chronic Graft Versus Host Disease (cGvHD) after 1 or More Lines of Systemic Treatment. Blood. 144(Supplement 1). 99–99. 1 indexed citations
7.
Shang, Limin, Yixin Yu, Yonghui Gao, et al.. (2024). Nanozyme-reinforced hydrogel coatings for prevention of catheter-associated urinary tract infection. Nano Today. 56. 102271–102271. 21 indexed citations
8.
Yu, Yixin, Xudong Xu, Xuemei Tang, et al.. (2023). Rational Design of Orally Administered Cascade Nanozyme for Inflammatory Bowel Disease Therapy. Advanced Materials. 35(44). e2304967–e2304967. 58 indexed citations
9.
Bi, Jianping, Rui Meng, Dongqin Yang, et al.. (2023). Dosimetric predictors of radiation pneumonitis in patients with prior immunotherapy exposure: A multi-institutional analysis. Radiotherapy and Oncology. 190. 110040–110040. 8 indexed citations
10.
Lv, Bin, Yida Pan, Ping Chen, et al.. (2022). RNF4 silencing induces cell growth arrest and DNA damage by promoting nuclear targeting of p62 in hepatocellular carcinoma. Oncogene. 41(16). 2275–2286. 7 indexed citations
11.
Ma, Liyun, Jianghong Yu, Bing Zhao, et al.. (2022). Effects of Immune Cells on Intestinal Stem Cells: Prospects for Therapeutic Targets. Stem Cell Reviews and Reports. 18(7). 2296–2314. 8 indexed citations
12.
Bi, Jianping, Jing Qian, Dongqin Yang, et al.. (2022). Dosimetric Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors. Frontiers in Immunology. 12. 828858–828858. 14 indexed citations
13.
Nakajima, Erika, et al.. (2021). Hermansky-Pudlak Syndrome and Lung Disease: Pathogenesis and Therapeutics. Frontiers in Pharmacology. 12. 644671–644671. 20 indexed citations
14.
Wang, Yudong, John H. Zhang, Hong Luo, et al.. (2020). USP19 Enhances MMP2/MMP9-Mediated Tumorigenesis in Gastric Cancer. SHILAP Revista de lepidopterología. 4 indexed citations
15.
Yang, Dongqin, Qi Zhang, Yunfang Ma, et al.. (2019). Augmenting the therapeutic efficacy of adenosine against pancreatic cancer by switching the Akt/p21-dependent senescence to apoptosis. EBioMedicine. 47. 114–127. 24 indexed citations
16.
Chen, Ping, et al.. (2018). Suppression of AURKA alleviates p27 inhibition on Bax cleavage and induces more intensive apoptosis in gastric cancer. Cell Death and Disease. 9(8). 781–781. 22 indexed citations
17.
Zhang, Ting‐juan, Jing‐dong Zhou, Dongqin Yang, et al.. (2017). TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia. Journal of Cellular Physiology. 233(8). 5838–5846. 25 indexed citations
18.
Lü, Bin, Jiucun Wang, Jun Zhang, et al.. (2013). Screening and verification of ssDNA aptamers targeting human hepatocellular carcinoma. Acta Biochimica et Biophysica Sinica. 46(2). 128–135. 5 indexed citations
19.
Luo, Zhongguang, Guangyang Yu, Hyuk Woo Lee, et al.. (2012). The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth. Cancer Research. 72(13). 3360–3371. 202 indexed citations
20.
Yang, Dongqin, Yongchao Zhao, Jie Liu, Yi Sun, & Lijun Jia. (2012). Protective autophagy induced byRBX1/ROC1knockdown or CRL inactivation via modulating the DEPTOR-MTOR axis. Autophagy. 8(12). 1856–1858. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026